Combined inhibition of tumour necrosis factor-alpha and interleukin-12/23 for long-standing, refractory psoriatic disease: a differential role for cytokine pathways?

Rheumatology (Oxford). 2018 Nov 1;57(11):2053-2055. doi: 10.1093/rheumatology/key199.

Gabriele De Marco^{1

2}, Dennis McGonagle^{1

2}, Hannah R Mathieson^{1

2}, Mira Merashli³, Conor Magee⁴, Oliver FitzGerald⁴, Mark Goodfield⁵, Helena Marzo-Ortega^{1

2}

¹ NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK.
² Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
³ Division of Rheumatology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
⁴ St Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Ireland.
⁵ Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

No abstract available

Publication types